“ Organon took a portfolio of more than 60 products, 9,000+ employees and over USD 6 billion in revenue; it is a large and complex organization that… ”
In Conversation
“ ... our R&D department, which is big and growing, participates in 80 percent of MSD’s global clinical trials, making the affiliate number one in Europe by… ”
“ AIFA has always favoured innovation and, in this context, has defined specific criteria with the aim of guaranteeing quick access to medicines that have a clear… ”
“ The MEA region has a lot of potential, as we see big projects underway and investments in healthcare in major markets. ”
“ ... if high drug prices are the problem – and this administration says that a lot – then generics and biosimilars are the solution. I think… ”
“ [COVID] forced us to look at how our systems and processes were able to deal with such high demand. . . we transformed the way we… ”
“ ... the Ichnos team has further accelerated our clinical stage pipeline in haematological malignancies to better position the firm and prepare it to host new investors… ”
“ The Spanish biosimilars industry is experiencing a reduction of prices, regulatory changes regarding product approval, and increased local and global competition, which is a complex topic… ”
“ ... we excel in supply chain, keeping in mind that our model is B2B; our success relies on delivering products on time so that clients can… ”
“ I am a great believer in the US system and feel that there is a lot of misinformation about it. ”
“ The technical and economic advantage of using zebrafish is due to the ability to study multiple organisms in a reduced space. ”
“ ... in Italy we have developed a dual strategy: on one side in-licence local generic products; while on the other side ... increase our business development… ”
